Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Access
1.1.4. End-use
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Access outlook
2.2.4. End-use outlook
2.3. Competitive Insights
Chapter 3. Extracorporeal CO2 Removal Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Extracorporeal CO2 Removal Devices Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Extracorporeal CO2 Removal Devices: Product Estimates & Trend Analysis
4.1. Extracorporeal CO2 Removal Devices Market: Key Takeaways
4.2. Extracorporeal CO2 Removal Devices Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Extracorporeal CO2 machines
4.3.1. Extracorporeal CO2 machines market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Disposables
4.4.1. Disposables market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Others
4.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Extracorporeal CO2 Removal Devices: Application Estimates & Trend Analysis
5.1. Extracorporeal CO2 Removal Devices Market, By Application Key Takeaways
5.2. Extracorporeal CO2 Removal Devices Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Acute respiratory distress syndrome (ARDS)
5.3.1. Acute respiratory distress syndrome (ARDS) market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Chronic obstructive pulmonary disease (COPD)
5.4.1. Chronic obstructive pulmonary disease (COPD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Bridge to lung transplant
5.5.1. Bridge to lung transplant market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Extracorporeal CO2 Removal Devices: Access Estimates & Trend Analysis
6.1. Extracorporeal CO2 Removal Devices Market, By Access Key Takeaways
6.2. Extracorporeal CO2 Removal Devices Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Venovenous
6.3.1. Venovenous market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Arteriovenous
6.4.1. Arteriovenous market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Extracorporeal CO2 Removal Devices: End-use Estimates & Trend Analysis
7.1. Extracorporeal CO2 Removal Devices Market, By End-use Key Takeaways
7.2. Extracorporeal CO2 Removal Devices Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Ambulatory Surgical Centers
7.4.1. Ambulatory surgical centers market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Clinics
7.5.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Extracorporeal CO2 Removal Devices: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Moist Wound Dressing Market by Region: Key Marketplace Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Medtronic
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Getinge AB
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Xenios AG
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. ALung Technologies, Inc.
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. ESTOR S.P.A.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Medica S.P.A.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Aferetica srl
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer